BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9716604)

  • 1. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma.
    Rao PH; Cigudosa JC; Ning Y; Calasanz MJ; Iida S; Tagawa S; Michaeli J; Klein B; Dalla-Favera R; Jhanwar SC; Ried T; Chaganti RS
    Blood; 1998 Sep; 92(5):1743-8. PubMed ID: 9716604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma.
    Sawyer JR; Lukacs JL; Thomas EL; Swanson CM; Goosen LS; Sammartino G; Gilliland JC; Munshi NC; Tricot G; Shaughnessy JD; Barlogie B
    Br J Haematol; 2001 Jan; 112(1):167-74. PubMed ID: 11167798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
    Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
    Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
    Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping.
    Sawyer JR; Lukacs JL; Munshi N; Desikan KR; Singhal S; Mehta J; Siegel D; Shaughnessy J; Barlogie B
    Blood; 1998 Dec; 92(11):4269-78. PubMed ID: 9834233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma.
    Nanjangud G; Rao PH; Hegde A; Teruya-Feldstein J; Donnelly G; Qin J; Jhanwar SC; Zelenetz AD; Chaganti RS
    Blood; 2002 Apr; 99(7):2554-61. PubMed ID: 11895793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicolor spectral karyotyping of serous ovarian adenocarcinoma.
    Rao PH; Harris CP; Yan Lu X; Li XN; Mok SC; Lau CC
    Genes Chromosomes Cancer; 2002 Feb; 33(2):123-32. PubMed ID: 11793438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia.
    Taniwaki M; Nishida K; Takashima T; Nakagawa H; Fujii H; Tamaki T; Shimazaki C; Horiike S; Misawa S; Abe T
    Blood; 1994 Oct; 84(7):2283-90. PubMed ID: 7919347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non-random abnormality that is frequently associated with Burkitt's-type translocations.
    Mugneret F; Sidaner I; Favre B; Manone L; Maynadié M; Caillot D; Solary E
    Leukemia; 1995 Feb; 9(2):277-81. PubMed ID: 7869764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
    Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
    Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene.
    Richelda R; Ronchetti D; Baldini L; Cro L; Viggiano L; Marzella R; Rocchi M; Otsuki T; Lombardi L; Maiolo AT; Neri A
    Blood; 1997 Nov; 90(10):4062-70. PubMed ID: 9354676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent chromosomal rearrangements involving breakpoints 3p21 and 19q13 in Chinese IgD multiple myeloma detected by G-banding and multicolor spectral karyotyping: a review of IgD karyotype literature.
    Ng MH; Wong N; Tsang KS; Cheng SH; Chung YF; Lo KW
    Hum Pathol; 2001 Sep; 32(9):1016-20. PubMed ID: 11567234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
    Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
    Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization.
    Finelli P; Fabris S; Zagano S; Baldini L; Intini D; Nobili L; Lombardi L; Maiolo AT; Neri A
    Blood; 1999 Jul; 94(2):724-32. PubMed ID: 10397739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel cryptic translocations involving IGH in B-cell non-Hodgkin's lymphomas.
    Gozzetti A; Davis EM; Espinosa R; Fernald AA; Anastasi J; Le Beau MM
    Cancer Res; 2002 Oct; 62(19):5523-7. PubMed ID: 12359763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.
    Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T
    Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of three novel translocations and specific common chromosomal break sites in malignant melanoma by spectral karyotyping.
    Sargent LM; Nelson MA; Lowry DT; Senft JR; Jefferson AM; Ariza ME; Reynolds SH
    Genes Chromosomes Cancer; 2001 Sep; 32(1):18-25. PubMed ID: 11477657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of complex chromosomal abnormalities in B-cell lymphoma by a combined spectral karyotyping (SKY) analysis and fluorescence in situ hybridization (FISH) using a 14q telomere probe.
    Kakazu N; Kito K; Hitomi T; Oita J; Nishida K; Masuda K; Miki T; Abe T
    Am J Hematol; 2000 Dec; 65(4):291-7. PubMed ID: 11074557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
    Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
    Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses.
    Sáez B; Martín-Subero JI; Largo C; Martín MC; Odero MD; Prosper F; Siebert R; Calasanz MJ; Cigudosa JC
    Cancer Genet Cytogenet; 2006 Sep; 169(2):143-9. PubMed ID: 16938572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.